Skip to content

XENETIC BIOSCIENCES, INC.: 10-Q filed 2020-08-12

What XENETIC BIOSCIENCES, INC. reported in its quarterly report filed 2020-08-12 (fiscal Q2 2020): 33 published measures, 93 facts as tagged in accession 0001683168-20-002645.

This filing

Form
10-Q (quarterly report)
Filed
2020-08-12
Fiscal period
fiscal Q2 2020
Accession
0001683168-20-002645 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All XENETIC BIOSCIENCES, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2020-06-3019,063,358USD
At 2019-12-3121,546,926USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2020-06-303,705,846USD
At 2019-12-314,333,675USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2020-06-3015,357,512USD
At 2020-03-3116,199,420USD
At 2019-12-3117,213,251USD
At 2019-06-3010,390,791USD
At 2019-03-3111,518,528USD
At 2018-12-319,912,788USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2020-04-01 to 2020-06-30-953,642USD91
2020-01-01 to 2020-06-30-2,133,071USD182
2019-04-01 to 2019-06-30-1,377,400USD91
2019-01-01 to 2019-06-30-2,704,650USD181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2020-01-01 to 2020-06-30-2,301,460USD182
2019-01-01 to 2019-06-30-2,305,456USD181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2020-04-01 to 2020-06-30112,927USD91
2020-01-01 to 2020-06-30169,676USD182
2019-04-01 to 2019-06-300USD91
2019-01-01 to 2019-06-300USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2020-01-01 to 2020-06-300USD182
2019-01-01 to 2019-06-302,699,559USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2020-01-01 to 2020-06-300USD182
2019-01-01 to 2019-06-302,000USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2020-06-30-168,141,691USD
At 2019-12-31-166,008,620USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2020-04-01 to 2020-06-300USD91
2020-01-01 to 2020-06-300USD182
2019-04-01 to 2019-06-300USD91
2019-01-01 to 2019-06-300USD181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2020-06-300USD
At 2019-12-31757USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2020-01-01 to 2020-06-30277,332USD182
2019-01-01 to 2019-06-30450,667USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2020-04-01 to 2020-06-30-982,459USD91
2020-01-01 to 2020-06-30-2,213,241USD182
2019-04-01 to 2019-06-30-1,378,298USD91
2019-01-01 to 2019-06-30-2,705,453USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2020-06-309,115,799USD
At 2019-12-3111,089,999USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2020-06-30787,328USD
At 2019-12-311,415,157USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2020-06-30250,075USD
At 2019-12-31931,128USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2020-04-01 to 2020-06-301,095,386USD91
2020-01-01 to 2020-06-302,382,917USD182
2019-04-01 to 2019-06-301,378,298USD91
2019-01-01 to 2019-06-302,705,453USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2020-04-01 to 2020-06-30307,900USD91
2020-01-01 to 2020-06-30667,551USD182
2019-04-01 to 2019-06-30487,519USD91
2019-01-01 to 2019-06-30951,301USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2020-06-306,296,227shares
At 2019-12-316,065,441shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2020-06-308,066,460USD
At 2019-12-3110,367,920USD
At 2019-06-301,034,218USD
At 2018-12-31638,115USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2020-06-30188,517,553USD
At 2019-12-31188,240,451USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2020-06-30253,734USD
At 2019-12-31253,734USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2020-06-3057,027USD
At 2019-12-3157,027USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2020-06-3057,027USD
At 2019-12-3156,270USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2020-06-30704,431USD
At 2019-12-311,213,042USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2020-06-301,049,339USD
At 2019-12-31722,079USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2020-04-01 to 2020-06-30-953,642USD91
2020-01-01 to 2020-06-30-2,133,071USD182
2019-04-01 to 2019-06-30-1,377,400USD91
2019-01-01 to 2019-06-30-6,584,097USD181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2020-04-01 to 2020-06-30787,486USD91
2020-01-01 to 2020-06-301,715,366USD182
2019-04-01 to 2019-06-30890,779USD91
2019-01-01 to 2019-06-301,754,152USD181

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2020-04-01 to 2020-06-30200USD91
2020-01-01 to 2020-06-30757USD182
2019-04-01 to 2019-06-301,000USD91
2019-01-01 to 2019-06-302,412USD181

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2020-04-01 to 2020-06-30192USD91
2020-01-01 to 2020-06-3058USD182
2019-04-01 to 2019-06-30735USD91
2019-01-01 to 2019-06-30490USD181

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2020-04-01 to 2020-06-3028,817USD91
2020-01-01 to 2020-06-3080,170USD182
2019-04-01 to 2019-06-30898USD91
2019-01-01 to 2019-06-30803USD181

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2020-01-01 to 2020-06-300USD182
2019-01-01 to 2019-06-308USD181

Operating lease payments

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

PeriodValueUnitDays
2020-01-01 to 2020-06-3013,765USD182

Inspect the source

Entity
XENETIC BIOSCIENCES, INC. / CIK 0001534525
Captured
2026-09-20T09:16:43.632Z
SEC response SHA-256
0d9d849e14a36c3c398086c2983f13053152bb5ab9dbb765c6ab6226c86b34ff

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001534525.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))